More than a year has passed since the first confirmed case of SARS-CoV-2 infection in the US was reported on January 20, 2020. What followed was an unprecedented year with nearly 30 million documented infections and more than 500 000 excess deaths in the US due to SARS-CoV-2. Alongside this devastation is the successful development and deployment of multiple safe and effective vaccines.1